Wholesale Nitroxoline 5-Nitro-8-quinolinol CAS 4008-48-4 from China Suppliers and Factory with COA & SDS Available
Product parameters
| Product Name | Nitroxoline |
| CAS NO | 4008-48-4 |
| Structure |
|
| Molecular formula | C9H6N2O3 |
| Purity | Over 99.5% |
| Other product names | 5-Nitro-8-quinolinol, 8-Hydroxy-5-nitroquinoline, 5-Nitro-8-hydroxyquinoline, 5-nitroquinolin-8-ol |
| Molecular weight | 190.16 |
In vitro activity
Using spectrophotometric fluorescence assay, Nitroxoline can significantly reduce the degradation of extracellular DQ collagen IV in all tested cancer cell lines. Nitroxoline can significantly reduce real-time monitoring of tumor cell invasion and decrease the invasive growth of multicellular tumor spheroids, which can be used as a three-dimensional vitreous model of tumor invasion. In vitro angiogenesis experiments, Nitroxoline can significantly reduce the formation of endothelial tubes.
In vivo activity
Nitroxoline significantly inhibited tumor growth, angiogenesis and metastasis in LPB fibrosarcoma and MMTV PyMT breast cancer mouse models.
Kinase experiment
In Vitro Kinase Assays : The potency of SP600125 towards kinases, including MPS1, JNK, and Aurora kinase A, is determined based on the specific measurement of radioactive phosphotransfer to the substrate. For each enzyme, the absolute Km values for ATP and the specific substrate are initially determined and each assay is then run at optimized [ATP] (2·αKm) and [substrate] (5·Km) concentrations. MPS1 activity is measured using 5 nM of MPS1 recombinant protein in 50 mM HEPES pH 7.5, 2.5 mM MgCl2, 1 mM MnCl2, 1 mM DTT, 3 μM NaVO3, 2 mM β-glycerophosphate, 0.2 mg/mL BSA, 200 μM P38-βtide substrate-peptide (KRQADEEMTGYVATRWYRAE), and 8 μM ATP with 1.5 nM 33P-γ-ATP. Ten serial 1:3 dilutions (from 30 μM to 1.5 nM) of SP600125 are tested and IC50 determined.
Cell experiment
Cell suspension are seeded in the wells of an E-plate 16 according to the manufacturer's instructions. After seeding, the CI is monitored every 15 min. After ∼10 h (MCF-10A neoT and MMTV-PyMT), 14 h (U-87 MG) or 24 h (LPB), when the cells are in their log phase of growth, 50 μl of the compound or 0.1% DMSO is added, and the experiment allowed to run for 72 h. Once every 24 h the medium is replaced with fresh medium containing the inhibitor or suitable control to prevent cell death due to medium depletion. Compounds and their concentrations are: nitroxoline (5 μM) and CA-074 (5 μM) for all cell lines other than MCF-10A neoT cell line, where nitroxoline was used at 2.5 μM. All measurements were performed in quadruplicate. (Only for Reference)
Frequently Asked Questions
Q
What is the CAS number and molecular weight of Nitroxoline?
The CAS number of Nitroxoline is 4008-48-4, and its molecular weight is 190.16.
Q
What synonyms is Nitroxoline also known by?
Nitroxoline is also known as 5-Nitro-8-quinolinol, 8-Hydroxy-5-nitroquinoline, 5-Nitro-8-hydroxyquinoline, and 5-nitroquinolin-8-ol.
Q
What is the purity level of Nitroxoline?
The purity of Nitroxoline is certified to be over 99.5%.
Q
How does Nitroxoline perform in in vitro cancer cell studies?
In vitro, Nitroxoline significantly reduces extracellular DQ collagen IV degradation, decreases tumor cell invasion, limits the growth of multicellular tumor spheroids, and reduces endothelial tube formation.
Q
Does Nitroxoline show efficacy in in vivo animal models?
Yes, Nitroxoline has demonstrated significant inhibition of tumor growth, angiogenesis, and metastasis in both LPB fibrosarcoma and MMTV PyMT breast cancer mouse models.
Q
What is the typical concentration of Nitroxoline used in cell experiments?
A concentration of 5 μM is typically used for most cell lines, whereas a concentration of 2.5 μM is applied specifically for the MCF-10A neoT cell line.


Phone
Send Email
whatsapp


